Refractory Childhood Malignant Germ Cell Tumor: Clinical Trials

2 trials for Refractory Childhood Malignant Germ Cell Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1

Follow Refractory Childhood Malignant Germ Cell Tumor: new trials by email Literature Review of Refractory Childhood Malignant Germ Cell Tumor trials Research Report on Refractory Childhood Malignant Germ Cell Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Bone Scan - Advanced Malignant Solid Neoplasm, Recurrent Childhood Ependymoma
Phase 2Active not recruitingNational Cancer Institute (NCI)202018-06-052026-10-16
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Olaparib - Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)62017-09-142024-12-11

Narrower conditions

Central Nervous System Neoplasms (2)  ·  Ependymoma (2)  ·  Familial ependymoma (2)  ·  Glioma (2)  ·  Hepatoblastoma (2)  ·  Histiocytosis, Langerhans-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Medulloblastoma (2)  ·  Neuroblastoma (2)  ·  Neuroectodermal Tumors, Primitive, Peripheral (2)  ·  Rhabdoid Tumor (2)  ·  Wilms Tumor (2)  ·  Osteosarcoma (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genetic Diseases, Inborn (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Histiocytosis (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Kidney Diseases (2)  ·  Kidney Neoplasms (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Interstitial (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoproliferative Disorders (2)

Interventions

Biopsy (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nuclear Medicine Department, Hospital (1)  ·  Phantoms, Imaging (1)  ·  Specimen Handling (1)  ·  X-Rays (1)  ·  erdafitinib (1)  ·  olaparib (1)

Sponsors

National Cancer Institute (NCI) (2)

Countries

Puerto Rico (2)  ·  United States (2)

Top investigators

Alice Lee (1)  ·  Julia Glade-Bender (1)

Results publications

PMID 31401903, PMID 38815151

NIH funding

U10CA180886 (2), UM1CA081457 (1)